Dark

Check out our Level2View

BIOC
Biocept, Inc.
stock NASDAQ

Inactive

Oct 24, 2023

0.4349USD-13.055%(-0.0653)751,454

Pre-market

0.00USD-100.000%(-0.50)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 21, 2022

08:03AM EST Biocept Highlights Co. Has Received 40K+ Samples For COVID-19 Testing Since Beginning Of 2022 Benzinga

Jan 4, 2022

08:00AM EST Biocept to Present at the H.C. Wainwright BioConnect Virtual Conference on January 10 Business Wire

Dec 9, 2021

09:47PM EST Biocept's CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations In Patients With Breast Cancer That Has Metastasized To The Brain Benzinga

Dec 1, 2021

08:49AM EST Quest Diagnostics Now Offers Biocept's Liquid Biopsy Test For Lung Cancer Benzinga

Nov 22, 2021

01:57PM EST Biotechnologies; Test Quantifies Viral Load to Determine Infection Level and Disease Progression PR Newswire

08:25AM EST Biocept Launches Combined COVID-19 And Influenza Test To Provide Answers During Peak Flu Season Benzinga

Nov 18, 2021

08:25AM EST Biocept Says Co's CNSide Cerebrospinal Fluid Assay Aids In Monitoring Treatment Response And Detects Actionable Biomarkers In Patients with Metastatic Breast Cancer Benzinga

Nov 15, 2021

06:38PM EST Biocept Q3 EPS $0.03 Misses $0.06 Estimate, Sales $17.50M Beat $16.07M Estimate Benzinga

04:05PM EST Biocept Reports Third Quarter 2021 Financial Results Business Wire

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 9, 2021

11:44AM EST Biocept Highlights Publication Of Study Showing 'Switch-Blocker Technology Enhances Performance of Conventional PCR-Based Liquid Biopsy Assays in Detecting Rare Cancer Mutations' In Journal of Molecular Diagnostics Benzinga

Nov 8, 2021

08:00AM EST Biocept to Report Third Quarter 2021 Financial Results and Host Investor Conference Call on November 15, 2021 Business Wire

Oct 12, 2021

11:24AM EDT Cancer-Diagnostics Firm Biocept Has Seen Revenue Soar Since Getting Into Virus Testing Benzinga

Oct 6, 2021

08:28AM EDT Biocept To Present At LD Micro Main Event Wednesday, Oct. 13, 2021 At 2 p.m. EDT Benzinga

Sep 29, 2021

01:28PM EDT Biocept: A New Diagnostic Approach to Improve the Lives of Cancer Patients Benzinga

Sep 22, 2021

08:17AM EDT Biocept Implements COVID-19 Testing Program At Select California Community Colleges Benzinga

Sep 7, 2021

08:00AM EDT Biocept to Present at Four Virtual Investor Conferences in September Business Wire

Aug 31, 2021

09:25PM EDT Biocept Reports Inducement Grants Under Nasdaq Listing Rule RTTNews

08:00PM EDT Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 20, 2021

06:03AM EDT Pre-market Movers: GOVX, PROG, SONN, MRIN, RTTNews

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 16, 2021

04:34PM EDT Biocept Q2 EPS $(0.14) Up From $(0.51) YoY, Sales $12.00M Miss $17.76M Estimate Benzinga

04:34PM EDT Biocept Q2 EPS $(0.51) Down From $(0.05) YoY, Sales $12.00M Miss $17.76M Estimate Benzinga

04:05PM EDT Biocept Reports Second Quarter 2021 Financial Results Business Wire

04:04AM EDT Earnings Scheduled For August 16, 2021 Benzinga

Aug 15, 2021

12:16PM EDT The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

11:06AM EDT The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

Aug 9, 2021

08:00AM EDT Biocept to Report Second Quarter 2021 Financial Results and Host Investor Conference Call on August 16, 2021 Business Wire

Jul 21, 2021

11:42AM EDT Medicare Issues Coverage Determination For Biocept's Target Selector Assay For Breast Cancer Benzinga

08:19AM EDT Biocept Announces Local Coverage Determination That Expands Medicare Coverage For Co.'s Target Selector Breast Cancer Assay To Detect The HER2 Biomarker From Circulating Tumor Cells Benzinga

Jul 19, 2021

08:00AM EDT Biocept to Participate in Two July Investment Conferences Business Wire

Jul 6, 2021

08:27AM EDT Biocept Says Receives South Korean Patent For Primer-Switch Platform Used To Identify Rare Genetic Mutations, Including Cancer Biomarkers Benzinga

Jun 28, 2021

08:20AM EDT Biocept Joins Russell Microcap Index Benzinga

Jun 22, 2021

10:20AM EDT Biocept Stock Moves Higher On Collaboration With Quest Diagnostics For Liquid Biopsy Testing For Lung Cancer Patients Benzinga

Jun 15, 2021

08:18AM EDT Biocept Says Received More Than 420,000 Samples During First Year Of Offering COVID-19 Testing Service Benzinga

Jun 9, 2021

08:37AM EDT Biocept, CLEARED4 Collaborate To Develop New Service For Managing COVID-19 Testing And Results Reporting For Biocept Customers Benzinga

Jun 3, 2021

08:00AM EDT Biocept to Present at the LD Micro Virtual Invitational XI Conference on June 9, 2021 Business Wire

Jun 2, 2021

04:05PM EDT Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

May 13, 2021

04:01PM EDT MedTech Round Up: Update On Johnson & Johnson, Becton Dickinson, Labcorp, Second Sight Medical, Biocept Benzinga

06:10AM EDT Biocept Files Prospectus Supplement on Form 424B5 Related to Offering of Common Stock of Upto $25M Benzinga

May 12, 2021

04:48PM EDT Biocept Q1 EPS $0.19 Up From $(1.06) YoY, Sales $17.80M Beat $13.67M Estimate Benzinga

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

04:22AM EDT Earnings Scheduled For May 12, 2021 Benzinga

May 5, 2021

08:00AM EDT Biocept to Report First Quarter 2021 Financial Results and Host Investor Conference Call on May 12, 2021 Business Wire

Apr 28, 2021

08:32AM EDT Biocept to Supply COVID-19 Testing Through Partnership With the Foundation for California Community Colleges Benzinga

Apr 21, 2021

08:37AM EDT Biocept Announces Commercial Launch Of CNSide Cerebrospinal Fluid Assay Benzinga

Apr 14, 2021

08:09AM EDT Biocept Says Has Received Over 350K Samples For SARS-CoV-2 Testing Since June Benzinga

Apr 7, 2021

04:05PM EDT Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System Business Wire

Apr 1, 2021

05:00PM EDT Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

08:05AM EDT Biocept to Host Key Opinion Leader Webinar on April 8 to Discuss its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System Business Wire

Mar 30, 2021

08:06AM EDT The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings Benzinga

06:17AM EDT A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, House Price Data Benzinga

Mar 29, 2021

04:32PM EDT Biocept: Q4 Earnings Insights Benzinga

04:06PM EDT Biocept Q4 Sales $18.50M Beat $12.32M Estimate Benzinga

04:05PM EDT Biocept Reports 2020 Fourth Quarter and Full Year Financial Results Business Wire

04:16AM EDT Earnings Scheduled For March 29, 2021 Benzinga

Mar 27, 2021

01:01PM EDT The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week Benzinga

Mar 22, 2021

08:00AM EDT Biocept to Report 2020 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 29, 2021 Business Wire

Mar 9, 2021

07:00AM EST Biocept to Participate in Three Virtual Investment Conferences in March Business Wire

Mar 3, 2021

04:05PM EST Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Mar 2, 2021

08:08AM EST Biocept, Aegea Biotech Report Supply Deal For New PCR-Based COVID-19 Assay Kit Benzinga

Feb 23, 2021

12:35PM EST Biocept Inks Research Pact With Protean BioDiagnostics For Target Selector Kit Advantages In Lung Cancer Benzinga

08:12AM EST Biocept, Protean BioDiagnostics Report Establishment Of Research Collaboration To Show Advantages Of Biocept's Target Selector Assay Kit For Non-Small Cell Lung Cancer Patients Benzinga

Feb 16, 2021

08:21AM EST Biocept Shares See Volume; Co Says Study Shows Co's Target Selector Detects Mutations In 'Quantity Not Sufficient' Specimens In Non-Small Cell Lung Cancer Patients Benzinga

08:00AM EST Study Shows Biocept's Target Selector(tm) Detects Mutations in "Quantity Not Sufficient" Specimens in Non-Small Cell Lung Cancer Patients Business Wire

Feb 3, 2021

08:15AM EST Biocept Provides Update On COVID-19 Testing With More Than 250,000 Samples Received RTTNews

08:01AM EST Biocept Highlights Over 250K Samples Received To Date Benzinga

08:00AM EST Biocept Provides Update on COVID-19 Testing with More than 250,000 Samples Received Business Wire

Feb 2, 2021

04:05PM EST Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

08:32AM EST CORRECTION: Ticker For Bioceres Is 'BIOX' Benzinga

08:32AM EST Bioceres Reports Deal With Nature Source Improved Plants To Establish Advanced HB4 Soybean Breeding Program In US Benzinga

Jan 12, 2021

08:08AM EST Biocept Issues Letter To Stockholders Benzinga

Jan 4, 2021

08:05AM EST Biocept to Present at H.C. Wainwright Virtual BioConnect Conference PR Newswire

Dec 31, 2020

05:30PM EST Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire

Dec 30, 2020

08:14AM EST Biocept Announces That It Has Entered Into A Laboratory Services Agreements With Two Independent Physicians Associations Benzinga

08:09AM EST Biocept Enters Laboratory Services Agreements With 2 Southern California Regional Independent Physician Associations RTTNews

08:05AM EST Biocept Enters into Laboratory Services Agreements with Two Southern California PR Newswire

Dec 14, 2020

08:05AM EST Biocept Says it Has Received More Than 150K COVID-19 Samples for Testing Benzinga

08:01AM EST Biocept Provides Business Update PR Newswire

Dec 10, 2020

10:18AM EST Shares of commercial provider of molecular diagnostic assays, products and services, Biocept, Inc. (BIOC) are adding more than 18% Thursday morning. The company announced results from a prospective study showing that Biocept's Target Selector was highly accurate in monitoring HER2 alterations in patients with metastatic breast cancer. RTTNews

08:04AM EST Biocept Reports Its Target Selector Liquid Biopsy Showed 'High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center' Benzinga

08:01AM EST Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center PR Newswire

Dec 1, 2020

11:30AM EST While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare PR Newswire

Nov 20, 2020

08:12AM EST Biocept's Assays Viable And Sensitive For Detecting Tumor Cells RTTNews

08:03AM EST Biocept Reports Results Of Study Analyzing Cerebrospinal Fluid Samples In Patients with Primary Lung, Breast Cancer With Brain Or Leptomeningeal Disease Benzinga

08:01AM EST and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central Nervous System PR Newswire

Nov 17, 2020

08:07AM EST Biocept To Present Results From Study Using Biocept's Target Selector Testing To Monitor Breast Cancer Dec. 9 Benzinga

08:06AM EST Results from Study Using Biocept's Target Selector(tm) Testing to Monitor PR Newswire

Nov 13, 2020

07:40AM EST The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations Benzinga

Nov 12, 2020

04:08PM EST Biocept Q3 EPS $(0.43) Beats $(0.47) Estimate, Sales $6.60M Beat $2.51M Estimate Benzinga

04:06PM EST Biocept Reports Third Quarter 2020 Financial Results PR Newswire

08:54AM EST Stocktwits Trending Stocks For Thursday, Nov. 12, 2020: XPEV, PLTR, MPLN, WMT, HYLN, BIOC, PDD, CELH, PIC, REV Benzinga

08:43AM EST Stocks Trading Near 52-Week Highs Before Open On Thursday, Nov. 12, 2020: NWSA, MNKD, NBACW, CELH, BIOC, DNLI, FIT, THCBW, PANL, PXS, AXTI, RH, THCB, PDD, UPWK, PLUG, UN, SING, PLTR Benzinga

08:08AM EST Biocept Offers Update On COVID-19 Testing: 100K+ Samples Received To Date For Processing Benzinga

08:05AM EST Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples PR Newswire

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 11, 2020

11:21AM EST Biocept Shares Relatively Quiet; Co. Tweet Highlights Study Published Nov. 3 In 'Nature Communications' Benzinga

Nov 9, 2020

08:07AM EST Biocept Reports Wins Hong Kong Patent No. 1188285 For 'METHODS AND REAGENTS FOR SIGNAL AMPLIFICATION' Benzinga

08:05AM EST Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare PR Newswire

Nov 5, 2020

08:14AM EST Biocept Awarded Broad Japanese Patent For Use Of Binding Entities In Combination With Any Solid Surface To Capture And Detect Any Target Of Interest, Including CTCs, From Any Sample Type Benzinga

08:05AM EST Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any Sample Type PR Newswire

Nov 4, 2020

08:01AM EST Biocept to Release Third Quarter 2020 Financial Results and Host Investor PR Newswire

Oct 29, 2020

08:18AM EDT Biocept Provides Update On COVID-19 Testing With More Than 80K Samples Received Benzinga

08:05AM EDT Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples PR Newswire

Oct 21, 2020

08:10AM EDT Biocept Names Samuel Riccitelli To Its Board RTTNews

08:02AM EDT Biocept Appoints Samuel D. Riccitelli to its Board of Directors PR Newswire

Oct 6, 2020

08:01AM EDT Biocept Says Has Received Mored Than 50,000 COVID-19 Specimens To Date Benzinga

08:01AM EDT Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens PR Newswire

Oct 5, 2020

08:03AM EDT Study Shows Biocept's Target Selector May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology Benzinga

08:01AM EDT Study Shows Biocept's Target Selector(tm) May Provide a More Robust Method for PR Newswire

Oct 1, 2020

08:13AM EDT Biocept To Present Study Results From Target Selector Testing In Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting Benzinga

08:02AM EDT Biocept To Present Study Results From Target Selector Testing In Cerebrospinal Fluid Of Patients With Lung Cancer RTTNews

08:02AM EDT Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting PR Newswire

08:01AM EDT Biocept To Present Study Results From Target Selector Testing In Cerebrospinal Fluid Of Patients With Lung Cancer At The IASLC Liquid Biopsy Meeting Oct. 2 Benzinga

Sep 23, 2020

08:12AM EDT Biocept Announces Award Of Japanese Patent No. 6734887 RTTNews

08:04AM EDT Biocept Announces Award Of Japanese Patent For Primer-Switch Mutation Detection And Amplification Improvement Platform Used To Detect Rare Cell Mutations In Tissue, Blood And Cerebrospinal Fluid Benzinga

08:01AM EDT Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations in Tissue, Blood and Cerebrospinal Fluid PR Newswire

Sep 21, 2020

08:12AM EDT Biocept Announces Highmark Has Made A Positive Coverage Determination On Target Selector Liquid Biopsy Benzinga

08:01AM EDT Biocept Announces that Highmark Has Made a Positive Coverage Determination on PR Newswire

Sep 16, 2020

08:10AM EDT Biocept Provides COVID-19 Testing Update; Announces Distribution Of 83,000 Specimen Collection Kits To Clients RTTNews

08:01AM EDT Biocept Says Has Received Over 35,000 COVID-19 Specimens To Date, Has Distributed ~83,000 Collection Kits Benzinga

08:01AM EDT Biocept Provides COVID-19 Testing Update with More than 35,000 Specimens PR Newswire

Sep 14, 2020

08:01AM EDT Aegea Biotechnologies, Inc. Advances to Semi-Finals of the $5M XPRIZE Rapid PR Newswire

Sep 9, 2020

08:01AM EDT Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference PR Newswire

Sep 8, 2020

08:09AM EDT Biocept Enters In-Network Provider Agreement With Health Net Federal Services Extending Coverage For Its Liquid Biopsy Oncology Platform To TRICARE West Region Network Benzinga

08:01AM EDT Extending Coverage for its Liquid Biopsy Oncology Platform to the TRICARE West Region Network PR Newswire

05:05AM EDT Biocept Shares Trading Today on a 1:10 Reverse Stock Split Benzinga

Sep 4, 2020

04:32PM EDT Biocept Announces One-for-Ten Reverse Stock Split RTTNews

Aug 31, 2020

09:27AM EDT Biocept Provides COVID-19 Testing Update With More Than 21,000 COVID-19 Specimens Received RTTNews

09:26AM EDT Biocept Reports Received 21K+, Processed 20K+ Coronavirus Specimens To Date Using RT-PCR Technology At Its Lab Benzinga

09:25AM EDT Biocept Provides COVID-19 Testing Update with More Than 21,000 COVID-19 PR Newswire

Aug 27, 2020

08:01AM EDT Biocept to Present at the LD Micro 500 Virtual Conference PR Newswire

Aug 24, 2020

08:03AM EDT Biocept Announces Michael Dugan Chief Medical Officer and Medical Director Benzinga

08:00AM EDT Biocept Names Michael Dugan, M.D. Chief Medical Officer and GlobeNewswire Inc

Aug 20, 2020

08:30AM EDT Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients, announces that President and CEO Michael Nall will present at the Proactive One2One Virtual Investor Forum, North America on Tuesday, August 25 at 1:00 p.m. Eastern time (10 a.m. Pacific time). GlobeNewswire Inc

Aug 19, 2020

08:01AM EDT Biocept Expands Agreement With MultiPlan TO Include Coronavirus Testing Benzinga

08:00AM EDT Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing GlobeNewswire Inc

06:08AM EDT Biocept Collaborator Aegea Biotechnologies Announces the Issuance of U.S. Patent for Primer-Switch Nucleic Acid Probes for the Detection of Rare Genetic Events and for PCR Amplification Improvements Benzinga

05:03AM EDT Aegea Announces Issuance Of U.S. Patent For Primer-Switch Nucleic Acid Probes For Detection Of Rare Genetic Events RTTNews

05:00AM EDT Primer-Switch Nucleic Acid Probes for the Detection of Rare Genetic Events and for PCR Amplification Improvements PR Newswire

Aug 18, 2020

08:01AM EDT Biocept Awarded US Patent For proprietary Primer-Switch Mutation Detection And Amplification Improvement Platform Used To Detect Rare Cell Mutations, Including Cancer Biomarkers Benzinga

08:01AM EDT Amplification Improvement Platform Used to Detect Rare Cell Mutations, Including Cancer Biomarkers PR Newswire

Aug 13, 2020

08:22AM EDT Biocept Announces Agreement With Healthcare Group To Provide COVID-19 Testing To Multi-State Locations Benzinga

08:18AM EDT The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga

08:13AM EDT Biocept Announces Deal With Healthcare Group To Provide COVID-19 Testing To Multi-State Locations RTTNews

08:02AM EDT Biocept Announces Agreement with Healthcare Group to Provide COVID-19 Testing PR Newswire

Aug 12, 2020

04:24PM EDT Biocept Q2 EPS $(0.05) Up From $(0.38) YoY, Sales $917.47K Miss $1.45M Estimate Benzinga

04:06PM EDT Biocept Reports Second Quarter 2020 Financial Results PR Newswire

04:21AM EDT Earnings Scheduled For August 12, 2020 Benzinga

Aug 6, 2020

11:44AM EDT Why Biocept's Stock Is Trading Higher Today Benzinga

08:07AM EDT Biocept Reports Deal With Aegea Biotech To Develop Highly-Sensitive PCR-Based Coronavirus Assay Utilizing Patented Switch-Block PCR Technology Benzinga

08:05AM EDT Biocept, Aegea Biotechnologies To Develop PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology RTTNews

08:01AM EDT Sensitive PCR-based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology PR Newswire

Aug 4, 2020

08:01AM EDT Biocept to Release Second Quarter 2020 Financial Results and Host Investor PR Newswire

Aug 3, 2020

08:09AM EDT Biocept Announces Distribution Of Nearly 12,000 Specimen Collection Kits RTTNews

08:08AM EDT Biocept Reaches Coroanvirus Testing Milestone With More Than 7K Specimens Received, More Than 6.5K Processed; Shares Spiked On Release Of PR Benzinga

08:01AM EDT Biocept Reaches COVID-19 Testing Milestone with More than 7,000 Specimens PR Newswire

Jul 16, 2020

08:10AM EDT Leading Independent Proxy Advisory Firms ISS And Glass Lewis Both Support Biocept Proposal To Authorize Reverse Split Of Common Shares Benzinga

08:05AM EDT Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Support PR Newswire

Share